These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25030316)

  • 1. [Extraocular muscle involvement in patients with thyroid-associated orbitopathy].
    Karhanová M; Kovář R; Fryšák Z; Zapletalová J; Marešová K; Sín M; Heřman M
    Cesk Slov Oftalmol; 2014 Apr; 70(2):66-71. PubMed ID: 25030316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between magnetic resonance imaging and ultrasound measurements of eye muscle thickness in thyroid-associated orbitopathy.
    Karhanova M; Kovar R; Frysak Z; Sin M; Zapletalova J; Rehak J; Herman M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):307-12. PubMed ID: 24510024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
    Wu T; Tang DR; Wang F; Xia S; Sun FY
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
    [No Abstract]   [Full Text] [Related]  

  • 4. Ocular hypertension in patients with active thyroid-associated orbitopathy: a predictor of disease severity, particularly of extraocular muscle enlargement.
    Karhanová M; Kalitová J; Kovář R; Schovánek J; Karásek D; Čivrný J; Hübnerová P; Mlčák P; Šín M
    Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3977-3984. PubMed ID: 35834036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles].
    Yang M; Du BX; Wang YJ; He WM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):510-515. PubMed ID: 34018373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease.
    Lennerstrand G; Tian S; Isberg B; Landau Högbeck I; Bolzani R; Tallstedt L; Schworm H
    Acta Ophthalmol Scand; 2007 Mar; 85(2):192-201. PubMed ID: 17305734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MRI study of the thickness and width of the extraocular muscles in normal subjects].
    Li R; Xia S; Wang J; Sun F; Qi J
    Zhonghua Yan Ke Za Zhi; 2015 Jun; 51(6):434-8. PubMed ID: 26310117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy.
    Ben Simon GJ; Syed HM; Douglas R; McCann JD; Goldberg RA
    Am J Ophthalmol; 2004 Jun; 137(6):1145-7. PubMed ID: 15183812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between extraocular muscle size and motility restriction in thyroid eye disease.
    Dagi LR; Zoumalan CI; Konrad H; Trokel SL; Kazim M
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):102-10. PubMed ID: 21383547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractional anisotropy and diffusivity changes in thyroid-associated orbitopathy.
    Han JS; Seo HS; Lee YH; Lee H; Suh SI; Jeong EK; Sapkota N; Kim KJ
    Neuroradiology; 2016 Dec; 58(12):1189-1196. PubMed ID: 27844093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study.
    Gao Y; Chang Q; Li Y; Zhang H; Hou Z; Zhang Z; Li Z; Li D
    BMC Ophthalmol; 2022 Feb; 22(1):66. PubMed ID: 35144579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonic measurement of ocular rectus muscle thickness in patients with Graves' ophthalmopathy.
    Imbrasienė D; Jankauskienė J; Stanislovaitienė D
    Medicina (Kaunas); 2010; 46(7):472-6. PubMed ID: 20966620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy.
    Abdel Razek AA; El-Hadidy M; Moawad ME; El-Metwaly N; El-Said AA
    Neuroradiol J; 2017 Jun; 30(3):230-234. PubMed ID: 28379055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy.
    Higashiyama T; Nishida Y; Morino K; Ugi S; Nishio Y; Maegawa H; Ohji M
    Jpn J Ophthalmol; 2015 Mar; 59(2):124-30. PubMed ID: 25448468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graves exophthalmos unrelated to extraocular muscle enlargement. Superior rectus muscle inflammation may induce venous obstruction.
    Hudson HL; Levin L; Feldon SE
    Ophthalmology; 1991 Oct; 98(10):1495-9. PubMed ID: 1961633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between extraocular muscle enlargement and thyroid autoantibodies in thyroid eye disease.
    Koizumi T; Tanaka T; Umeda K; Komiyama D; Obata H
    Jpn J Ophthalmol; 2024 May; 68(3):250-258. PubMed ID: 38609717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraocular muscle enlargement in dysthyroid optic neuropathy.
    Rana K; Garg D; Yong LSS; Macri C; Tong JY; Patel S; Slattery J; Chan WO; Davis G; Selva D
    Can J Ophthalmol; 2024 Oct; 59(5):e542-e546. PubMed ID: 38114063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enlargement of the tensor intermuscularis muscle in Graves' ophthalmopathy. A computed tomographic and magnetic resonance imaging study.
    Goodall KL; Jackson A; Leatherbarrow B; Whitehouse RW
    Arch Ophthalmol; 1995 Oct; 113(10):1286-9. PubMed ID: 7575261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of extraocular muscle with high-field magnetic resonance in patients with Graves' ophthalmopathy with upper-lid retraction.
    Chen Y; Jin ZY; Zhang ZH; Xu DD; Meng W; Jiang B; Fang HY; Sun ZY; Chen Y; Sun HY; Feng F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):461-7. PubMed ID: 23134821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of activity of thyroid-associated Ophthalmopathy using short-tau inversion recovery (STIR) sequence.
    Ge Q; Zhang X; Wang L; Fan Y; Huang Q; Yao N; Long J; Liu C
    BMC Endocr Disord; 2021 Nov; 21(1):226. PubMed ID: 34774035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.